2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Fractures: new trials by email Literature Review of Fractures trials Research Report on Fractures
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ketamine Patient-Controlled Analgesia for Acute Pain Ketamine, Hydromorphone - Acute Pain, Multiple Trauma | Phase 3 | Terminated | University of Cincinnati | 20 | 2014-04-01 | 2017-09-21 |
| A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures rhBMP-2/CPM - Fractures | Phase 2 / Phase 3 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 367 | 2006-11-01 | 2013-02-28 |
Fractures, Bone (2) · Acute Pain (1) · Multiple Trauma (1) · Pain (1) · Wounds and Injuries (1)
Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Wounds and Injuries (1)
Hydromorphone (1) · Ketamine (1)
University of Cincinnati (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (2) · Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · Finland (1) · France (1) · Germany (1) · India (1) · Latvia (1) · Mexico (1) · Poland (1) · Romania (1) · Serbia (1) · Slovenia (1)
Eric W Mueller, Pharm.D. (1) · Sheila C Takieddine, Pharm.D. (1)